Analysis of worldwide surgical outcomes in COVID-19-infected patients: a gynecological oncology perspective.
Future Sci OA
; 6(10): FS0629, 2020 Aug 21.
Article
in English
| MEDLINE | ID: covidwho-750850
ABSTRACT
Coronavirus Disease 2019 (COVID-19) guidance limits all but the most urgent surgery in the United Kingdom. We review the literature and our experience in gynecology to assess perioperative outcomes. PubMed was searched with (surg*[Title])AND(COVID[Title]), (surg*[Title])AND(2019-nCoV[Title]), and (surg*[Title])AND(SARS-CoV-2[Title]), and 67 COVID-19-positive surgical patients across ten hospitals in four countries are included. Median mortality was 33%. Cardiac and pulmonary co-morbidities associated with higher risk of COVID-19-positive postoperative death. Mortality was high in neurosurgery (80%) and the lowest in gynecological oncology surgery (none). This analysis provides an evidence base on which to consider surgical risk assessment for different specialties. Risk of perioperative death needs to be assessed in the context of patients' co-morbidities and surgical specialty. An individualized approach toward surgical decision making is imperative.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
/
Reviews
Language:
English
Journal:
Future Sci OA
Year:
2020
Document Type:
Article
Affiliation country:
Fsoa-2020-0099
Similar
MEDLINE
...
LILACS
LIS